Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07335861 · ClinicalTrials.gov registry record · NA
Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers
A NA study, sponsored by NuScience Medical Biologics.
- Recruiting
- Registry status
- NA
- Development phase
- 122
- Enrollment target
NCT07335861 is a NA study that is actively recruiting participants, run by NuScience Medical Biologics. The registered enrollment target is 122 participants.
The verdict
NCT07335861, a NA study, is actively recruiting participants, sponsored by NuScience Medical Biologics.
- RECRUITING
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
Study Summary
This is a randomized controlled trial evaluating the efficacy of HYALOMATRIX in conjunction with standard of care vs. standard of care alone in treating venous leg ulcers.
Interventions
- OTHER Standard of Care
- DEVICE Hyalomatrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2026-05-14 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07335861
The ClinicalTrials.gov registry entry for NCT07335861 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NuScience Medical Biologics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT07335861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07335861 about?
NCT07335861 is a clinical study titled "Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers". This is a randomized controlled trial evaluating the efficacy of HYALOMATRIX in conjunction with standard of care vs. standard of care alone in treating venous leg ulcers.
What is the current status of trial NCT07335861?
This trial is currently recruiting. It is a NA study. The enrollment target is 122 participants. The study started on 2026-05-14. Estimated completion is 2027-01-31.
What interventions are being tested in trial NCT07335861?
The interventions under investigation include: Standard of Care (OTHER), Hyalomatrix (DEVICE).
Who is sponsoring clinical trial NCT07335861?
This trial is sponsored by NuScience Medical Biologics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.